Association between prior authorization for medications and health service use by medicaid patients with bipolar disorder

Psychiatric Services

Volumn 62, Issue 2, 2011, Pages 186-193

  Lu, Christine Y ^a,b   Adams, Alyce S ^a,b,c   Ross Degnan, Dennis ^a,b   Zhang, Fang ^a,b   Zhang, Yuting ^d   Salzman, Carl ^a   Soumerai, Stephen B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID; ANTICONVULSIVE AGENT;

ADULT; AGED; ARTICLE; BIPOLAR II DISORDER; COMMUNITY MENTAL HEALTH CENTER; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MENTAL DISEASE; MENTAL HEALTH SERVICE; OUTPATIENT; SCHIZOPHRENIA; ADOLESCENT; BIPOLAR DISORDER; COMPARATIVE STUDY; HEALTH SERVICE; KAPLAN MEIER METHOD; MAINE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COMMUNITY MENTAL HEALTH CENTERS; FEMALE; HEALTH SERVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MAINE; MALE; MEDICAID; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 79953058061     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.62.2.pss6202_0186     Document Type: Article

References (37)

1. Catlin A, Cowan C, Heffler S, et al: National health spending in 2005: the slowdown continues. Health Affairs 26:142-153, 2007
2. Huskamp HA: Managing psychotropic drug costs: will formularies work? Health Affairs 22(5):84-96, 2003
3. Huskamp HA, Stevenson DG, Donohue JM, et al: Coverage and prior authorization of psychotropic drugs under Medicare Part D. Psychiatric Services 58:308-310, 2007 (Pubitemid 46480045)
4. Crowley JS, Ashner D, Elam L: State Medicaid Outpatient Prescription Drug Policies: Findings From a National Survey, 2005 Update. Washington DC, Kaiser Commission on Medicaid and the Uninsured, Kaiser Family Foundation, 2005
5. Adams AS, Zhang F, LeCates RF, et al: Prior authorization for antidepressants in Medicaid effects among disabled dual enrollees. Archives of Internal Medicine 169:750-756, 2009
6. Zhang Y, Adams AS, Ross-Degnan D, et al: Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. Psychiatric Services 60:520-527, 2009
7. Soumerai SB, Zhang F, Ross-Degnan D, et al: Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Affairs 27(3): w185-w195, 2008, Web Exclusive, doi: 10.1377/hlthaff.27.3 (Pubitemid 351770278)
8. Soumerai SB: Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs 23(1):135-146, 2004
9. Murray CJL, Lopez AD, Jamison DT: The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bulletin of the World Health Organization 72:495-509, 1994
10. Kessler RC, Wai TC, Demler O, et al: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:617-627, 2005 (Pubitemid 40973437)
11. Guo JJ, Keck PE, Li H, et al: Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder. Psychiatric Services 58:1073-1078, 2007 (Pubitemid 47290865)
12. Goodwin G, Vieta E: Effective maintenance treatment: breaking the cycle of bipolar disorder. European Psychiatry 20:365-371, 2005 (Pubitemid 41318001)
13. Bowden CL, Krishnan AA: Pharmacotherapy for bipolar depression: an economic assessment. Expert Opinion on Pharmacotherapy 5:1101-1107, 2004 (Pubitemid 38702340)
14. Bauer M: Review: lithium reduces relapse rates in people with bipolar disorder. Evidence-Based Mental Health 7:72, 2004
15. Tohen M, Greil W, Calabrese JR, et al: Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. American Journal of Psychiatry 162:1281-1290, 2005 (Pubitemid 40905578)
16. Swann AC: Long-term treatment in bipolar disorder. Journal of Clinical Psychiatry 66:7-12, 2005
17. Bowden CL, Gitlin MJ, Keck PE, et al: Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry 159(Apr suppl):1-50, 2002 (Pubitemid 34274969)
18. Goodwin FK: Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. Journal of Clinical Psychiatry 63(suppl 10):5-12, 2002
19. Kruse GR, Rohland BM, Wu X: Factors associated with missed first appointments at a psychiatric clinic. Psychiatric Services 53:1173-1176, 2002 (Pubitemid 34976632)
20. Centorrino F, Hernàn MA, Drago-Ferrante G, et al: Factors associated with noncompliance with psychiatric outpatient visits. Psychiatric Services 52:378-380, 2001 (Pubitemid 32259675)
21. Cramer JA, Scheyer RD, Mattson RH: Compliance declines between clinic visits. Archives of Internal Medicine 150:1509-1510, 1990 (Pubitemid 20215692)
22. Mitchell AJ, Selmes T: Why don't patients attend their appointments? Maintaining engagement with psychiatric services. Advances in Psychiatric Treatment 13:423-434, 2007 (Pubitemid 351166347)
23. Saucier P, Bezanson L, Booth M, et al: Linked data analysis of dually eligible beneficiaries in New England. Health Care Financing Review 20:91-108, 1998 (Pubitemid 29237268)
24. Busch AB, Huskamp HA, Landrum MB: Quality of care in a Medicaid population with bipolar I disorder. Psychiatric Services 58:848-854, 2007 (Pubitemid 46985179)
25. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al: Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine 331:650-655, 1994 (Pubitemid 24276866)
26. Feldman S: Reflections on the 40th anniversary of the Community Mental Health Centers Act. Administration and Policy in Mental Health 31:369-380, 2004
27. Cutler DL, Bevilacqua J, McFarland BH: Four decades of community mental health: a symphony in four movements. Community Mental Health Journal 39:381-398, 2003 (Pubitemid 38076668)
28. Allison PD: Survival Analysis Using SAS: A Practical Guide. Cary, NC, SAS Institute, 1995
29. Gueorguieva R, Krystal JH: Move over ANOVA: progress in analyzing repeatedmeasures data and its reflection in papers published in the Archives of General Psychiatry. Archives of General Psychiatry 61:310-317, 2004 (Pubitemid 38295833)
30. Schneeweiss S, Seeger JD, Maclure M, et al: Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. American Journal of Epidemiology 154:854-864, 2001 (Pubitemid 33000813)
31. Lu CY, Soumerai SB, Ross-Degnan D, et al: Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Medical Care 48:4-9, 2010
32. Osterberg L, Blaschke T: Adherence to medication. New England Journal of Medicine 353:487-497, 2005 (Pubitemid 41127293)
33. DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care 42:200-209, 2004
34. Frank E, Gonzalez JM, Fagiolini A: The importance of routine for preventing recurrence in bipolar disorder. American Journal of Psychiatry 163:981-985, 2006 (Pubitemid 44464483)
35. El-Mallakh RS: Medication adherence and the use of long-acting antipsychotics in bipolar disorder. Journal of Psychiatric Practice 13:79-85, 2007
36. Gaudiano BA, Weinstock LM, Miller IW: Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behavior Modification 32:267-301, 2008
37. National Alliance on Mental Illness Maine. Record of calls in response to the 2003 implementation of limits on access to MaineCare Medications. National Alliance on Mental Illness Maine, 2003. Available at www.nami.org/content/ microsites186/nami-maine/home174/whats-new89/nami-maine-monitered-issues/ rxaccess.pdf